Free Trial

ORIX (IX) Financials

ORIX logo
$20.58 +0.10 (+0.46%)
Closing price 05/21/2025 03:59 PM Eastern
Extended Trading
$20.90 +0.32 (+1.56%)
As of 05/21/2025 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for ORIX

Annual Income Statements for ORIX

This table shows ORIX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019 3/31/2018
Net Income / (Loss) Attributable to Common Shareholders
2,289 2,187 2,613 1,739 2,825 2,908 2,946
Consolidated Net Income / (Loss)
2,239 2,237 2,659 1,779 2,862 2,937 3,026
Net Income / (Loss) Continuing Operations
2,239 2,237 2,659 1,779 2,862 2,937 3,026
Total Pre-Tax Income
3,108 2,954 4,195 2,600 3,850 3,554 4,097
Total Operating Income
2,385 2,530 2,412 2,340 2,517 2,959 3,163
Total Gross Profit
18,472 20,004 20,608 20,581 7,318 7,132 7,454
Total Revenue
18,611 20,065 20,653 20,726 21,279 21,867 26,935
Operating Revenue
18,611 20,065 20,653 20,726 - - -
Total Cost of Revenue
139 61 44 145 13,961 14,736 19,481
Other Cost of Revenue
139 61 44 145 - - -
Total Operating Expenses
16,087 17,474 18,196 18,241 4,802 4,173 4,291
Selling, General & Admin Expense
4,150 4,214 4,305 4,129 4,294 3,925 4,061
Other Operating Expenses / (Income)
11,925 13,242 13,598 14,031 367 214 166
Impairment Charge
11 17 294 81 140 34 64
Total Other Income / (Expense), net
723 424 1,783 260 1,333 595 934
Interest & Investment Income
243 166 202 4.35 634 296 471
Other Income / (Expense), net
479 257 1,581 256 699 299 463
Income Tax Expense
869 717 1,537 820 988 617 1,072
Net Income / (Loss) Attributable to Noncontrolling Interest
-50 50 45 40 38 30 80
Weighted Average Basic Shares Outstanding
1.21B 1.23B 1.26B 1.29B 1.32B 1.32B -
Weighted Average Diluted Shares Outstanding
1.21B 1.23B 1.26B 1.29B 1.32B 1.32B -
Weighted Average Basic & Diluted Shares Outstanding
1.21B 1.23B 1.26B 1.29B 1.32B 1.32B -
Cash Dividends to Common per Share
$0.57 $0.67 $0.68 $76.00 $81.00 $69.00 $0.53

Quarterly Income Statements for ORIX

No quarterly income statements for ORIX are available.


Annual Cash Flow Statements for ORIX

This table details how cash moves in and out of ORIX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019 3/31/2018
Net Change in Cash & Equivalents
-1,201 2,072 101 -504 -1,384 -1,092 2,558
Net Cash From Operating Activities
8,222 6,878 9,086 9,966 9,728 5,278 5,352
Net Cash From Continuing Operating Activities
8,222 6,878 9,086 9,966 9,728 5,278 5,352
Net Income / (Loss) Continuing Operations
2,239 2,237 2,659 1,779 2,862 2,937 3,026
Consolidated Net Income / (Loss)
2,239 2,237 2,659 1,779 2,862 2,937 3,026
Depreciation Expense
2,409 2,563 2,638 2,856 2,839 2,655 2,634
Non-Cash Adjustments To Reconcile Net Income
1,930 1,980 1,071 3,243 2,760 -1,386 -653
Changes in Operating Assets and Liabilities, net
1,645 98 2,718 2,087 1,267 1,072 345
Net Cash From Investing Activities
-9,078 -8,275 -6,660 -10,938 -13,722 -7,849 -4,131
Net Cash From Continuing Investing Activities
-9,078 -8,275 -6,660 -10,938 -13,722 -7,849 -4,131
Purchase of Property, Plant & Equipment
-7,941 -8,136 -7,553 -6,877 -9,265 -9,522 -9,891
Acquisitions
-281 -1,558 -721 -743 -1,259 -1,070 -621
Purchase of Investments
-5,255 -4,803 -5,337 -7,942 -7,556 -8,094 -5,174
Sale of Property, Plant & Equipment
1,737 1,759 1,211 1,256 3,168 3,855 2,690
Divestitures
1,081 937 2,533 899 1,603 1,015 1,110
Sale and/or Maturity of Investments
1,982 3,049 3,250 3,148 3,418 3,397 5,624
Other Investing Activities, net
-401 478 -43 -679 -3,831 2,569 2,129
Net Cash From Financing Activities
-565 3,302 -2,525 361 2,694 1,497 1,327
Net Cash From Continuing Financing Activities
-565 3,302 -2,525 361 2,694 1,497 1,327
Repayment of Debt
-7,797 -8,861 -9,697 -9,662 -7,654 -8,932 -12,741
Repurchase of Common Equity
-331 -392 -412 -501 -427 -6.35 -368
Payment of Dividends
-661 -1,150 -836 -904 -1,011 -1,568 -791
Issuance of Debt
8,131 13,868 8,618 10,589 8,630 10,094 14,002
Issuance of Common Equity
103 30 214 221 224 204 45
Other Financing Activities, net
-10 -193 -412 617 2,932 1,705 1,179
Effect of Exchange Rate Changes
220 167 200 108 -84 -17 12

Quarterly Cash Flow Statements for ORIX

No quarterly cash flow statements for ORIX are available.


Annual Balance Sheets for ORIX

This table presents ORIX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019
Total Assets
107,936 115,174 117,512 122,609 121,940 109,343
Total Current Assets
60,752 69,427 69,295 73,357 75,007 58,628
Cash & Equivalents
6,830 9,280 7,863 8,599 9,170 10,427
Restricted Cash
1,008 1,017 1,128 1,160 1,424 1,101
Short-Term Investments
26,179 29,416 31,807 33,183 34,904 29,437
Accounts Receivable
2,654 3,328 2,964 3,203 2,918 2,520
Inventories, net
1,503 1,273 1,149 1,285 1,176 1,039
Other Current Assets
15,324 17,412 16,245 17,333 15,858 14,105
Other Current Nonoperating Assets
7,254 7,700 8,140 8,593 10,087 0.00
Plant, Property, & Equipment, net
4,560 4,678 4,627 4,446 5,249 15,964
Plant, Property & Equipment, gross
4,560 4,678 4,627 4,446 5,249 15,964
Total Noncurrent Assets
21,578 21,487 31,541 32,075 41,684 34,750
Long-Term Investments
21,578 21,487 31,541 32,075 28,620 24,892
Total Liabilities & Shareholders' Equity
107,936 115,174 117,512 122,609 121,940 109,343
Total Liabilities
81,322 87,941 89,750 94,557 93,235 82,732
Total Current Liabilities
21,478 23,708 25,713 26,287 26,870 23,106
Short-Term Debt
3,796 3,833 3,620 2,778 3,143 2,780
Accounts Payable
2,397 2,763 2,400 2,357 2,638 2,636
Customer Deposits
14,851 16,922 18,743 20,952 20,825 17,313
Current Deferred & Payable Income Tax Liabilities
433 190 950 200 263 377
Total Noncurrent Liabilities
59,843 64,233 64,037 68,269 66,365 59,626
Long-Term Debt
37,207 39,245 36,455 39,928 39,933 37,596
Noncurrent Deferred & Payable Income Tax Liabilities
3,341 3,232 2,848 3,085 3,062 2,819
Other Noncurrent Operating Liabilities
19,296 21,756 24,735 25,256 23,370 19,211
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
17 7.12 0.00 - 96 88
Total Equity & Noncontrolling Interests
26,597 27,227 27,762 28,052 28,609 26,523
Total Preferred & Common Equity
26,064 26,694 26,856 27,377 27,935 26,019
Total Common Equity
26,064 26,694 26,856 27,377 27,935 26,019
Common Stock
3,006 3,422 3,966 4,343 4,467 4,300
Retained Earnings
21,556 23,009 23,957 24,811 25,703 22,952
Treasury Stock
-860 -913 -934 -1,012 -1,130 -682
Accumulated Other Comprehensive Income / (Loss)
2,362 1,176 -132 -765 -1,106 -551
Noncontrolling Interest
532 533 906 675 674 504

Quarterly Balance Sheets for ORIX

No quarterly balance sheets for ORIX are available.


Annual Metrics And Ratios for ORIX

This table displays calculated financial ratios and metrics derived from ORIX's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019 3/31/2018 3/31/2017 3/31/2016 3/31/2015 3/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-7.25% -2.84% -0.35% -2.60% -2.69% -18.81% 0.00% 13.31% 16.89% 36.83% 17.55%
EBITDA Growth
-1.45% -19.30% 21.63% -9.96% 2.40% -5.55% 6.92% 10.69% 16.63% -0.97% 27.07%
EBIT Growth
2.75% -30.18% 53.85% -19.30% -1.29% -10.15% 1.37% 15.54% 18.26% 1.25% 51.86%
NOPAT Growth
-10.31% 25.36% -4.55% -14.41% -23.48% 4.68% 19.54% 9.46% 12.30% 23.72% 15.26%
Net Income Growth
0.10% -15.86% 49.43% -37.84% -2.55% -2.93% 0.00% 3.90% 13.88% 13.13% 47.55%
EPS Growth
0.00% 0.00% 0.00% 0.00% -6.15% 3.50% 0.00% 5.12% 10.78% 25.15% 63.90%
Operating Cash Flow Growth
19.54% -24.30% -8.83% 2.45% 84.31% -1.38% 0.00% 14.60% 112.60% -53.35% 9.89%
Free Cash Flow Firm Growth
96.18% -824.38% -95.70% -4.30% 1,072.92% -73.52% 34.47% 461.83% -106.69% 1,293.70% 177.71%
Invested Capital Growth
10.42% 26.40% 3.49% -105.93% -1,199.40% 0.00% 0.00% -39.80% 179.45% -89.73% 1.27%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
99.26% 99.70% 99.79% 99.30% 34.39% 32.61% 27.67% 31.07% 33.66% 37.94% 44.59%
EBITDA Margin
28.33% 26.67% 32.11% 26.30% 28.45% 27.04% 23.24% 24.35% 24.92% 24.98% 34.51%
Operating Margin
12.82% 12.61% 11.68% 11.29% 11.83% 13.53% 11.74% 12.29% 12.15% 11.81% 14.76%
EBIT Margin
15.39% 13.89% 19.33% 12.52% 15.11% 14.90% 13.46% 14.87% 14.59% 14.42% 19.48%
Profit (Net Income) Margin
12.03% 11.15% 12.87% 8.58% 13.45% 13.43% 11.23% 10.49% 11.44% 11.74% 14.20%
Tax Burden Percent
72.04% 75.71% 63.37% 68.44% 74.35% 82.64% 73.84% 66.11% 69.25% 74.20% 68.20%
Interest Burden Percent
108.49% 105.97% 105.07% 100.17% 119.71% 109.09% 113.00% 106.66% 113.22% 109.74% 106.85%
Effective Tax Rate
27.96% 24.29% 36.63% 31.56% 25.65% 17.36% 26.16% 33.89% 30.75% 25.89% 34.42%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 432.75% 0.00% 55.83% 60.18% 18.93% 8.49%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 428.88% 0.00% 52.92% 56.63% 14.39% -2.21%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% -410.67% 0.00% -44.88% -48.66% -8.45% 0.60%
Return on Equity (ROE)
8.32% 8.13% 9.53% 6.27% 10.35% 22.08% 0.00% 10.95% 11.52% 10.49% 9.09%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 232.75% 0.00% 105.52% -34.41% 181.69% 7.23%
Operating Return on Assets (OROA)
2.57% 2.40% 3.33% 2.12% 2.78% 2.98% 0.00% 3.59% 3.19% 2.86% 2.96%
Return on Assets (ROA)
2.01% 1.92% 2.21% 1.46% 2.48% 2.69% 0.00% 2.53% 2.50% 2.33% 2.15%
Return on Common Equity (ROCE)
8.15% 7.92% 9.26% 6.11% 10.09% 21.58% 0.00% 10.28% 10.58% 9.41% 8.12%
Return on Equity Simple (ROE_SIMPLE)
8.59% 8.38% 9.90% 6.50% 10.25% 11.29% 0.00% 11.20% 11.73% 11.86% 10.17%
Net Operating Profit after Tax (NOPAT)
1,718 1,916 1,528 1,601 1,871 2,445 2,336 1,954 1,785 1,590 1,285
NOPAT Margin
9.23% 9.55% 7.40% 7.73% 8.79% 11.18% 8.67% 8.12% 8.41% 8.75% 9.68%
Net Nonoperating Expense Percent (NNEP)
1.18% 0.66% 2.13% 0.38% 2.98% 3.86% 0.00% 2.91% 3.55% 4.54% 10.70%
Cost of Revenue to Revenue
0.75% 0.30% 0.21% 0.70% 65.61% 67.39% 72.33% 68.93% 66.34% 62.06% 55.41%
SG&A Expenses to Revenue
22.30% 21.00% 20.84% 19.92% 20.18% 17.95% 15.08% 15.63% 17.84% 19.68% 23.04%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
86.44% 87.08% 88.11% 88.01% 22.57% 19.08% 15.93% 18.78% 21.52% 26.12% 29.83%
Earnings before Interest and Taxes (EBIT)
2,865 2,788 3,993 2,595 3,216 3,258 3,626 3,577 3,096 2,618 2,585
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
5,273 5,351 6,631 5,451 6,055 5,913 6,260 5,855 5,289 4,535 4,579
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.04 0.77 0.96 0.82 0.00 0.00 0.00 0.75 0.76 0.84 0.08
Price to Tangible Book Value (P/TBV)
1.04 0.77 0.96 0.82 0.00 0.00 0.00 0.75 0.76 0.84 0.08
Price to Revenue (P/Rev)
1.46 1.03 1.24 1.08 0.00 0.00 0.00 0.70 0.74 0.83 0.11
Price to Earnings (P/E)
11.89 9.44 9.82 12.92 0.00 0.00 0.00 6.89 6.75 7.68 0.79
Dividend Yield
0.00% 0.00% 0.00% 2.32% 6.09% 5.15% 3.72% 3.67% 3.31% 0.00% 0.00%
Earnings Yield
8.41% 10.59% 10.18% 7.74% 0.00% 0.00% 0.00% 14.51% 14.80% 13.03% 126.91%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.71 0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
2.50 0.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
4.60 1.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
7.67 1.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
1.60 0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.54 1.58 1.44 1.52 1.50 1.52 0.00 1.56 1.73 1.85 1.94
Long-Term Debt to Equity
1.40 1.44 1.31 1.42 1.39 1.41 0.00 1.45 1.59 1.73 1.79
Financial Leverage
-1.64 -1.78 -1.90 -1.67 -1.20 -0.96 0.00 -0.85 -0.86 -0.59 -0.27
Leverage Ratio
4.14 4.23 4.30 4.31 4.18 4.11 0.00 4.33 4.61 4.50 4.22
Compound Leverage Factor
4.50 4.48 4.52 4.32 5.01 4.48 0.00 4.62 5.21 4.94 4.51
Debt to Total Capital
60.64% 61.27% 59.08% 60.35% 60.01% 60.28% 0.00% 60.93% 63.35% 64.94% 65.94%
Short-Term Debt to Total Capital
5.61% 5.45% 5.34% 3.93% 4.38% 4.15% 0.00% 4.17% 5.17% 4.19% 4.89%
Long-Term Debt to Total Capital
55.03% 55.82% 53.74% 56.43% 55.63% 56.13% 0.00% 56.75% 58.18% 60.75% 61.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.81% 0.77% 1.34% 0.95% 1.07% 0.88% 0.00% 2.16% 2.51% 3.42% 3.65%
Common Equity to Total Capital
38.55% 37.97% 39.59% 38.69% 38.92% 38.84% 0.00% 36.92% 34.14% 31.64% 30.41%
Debt to EBITDA
7.78 8.05 6.04 7.83 7.11 6.83 0.00 6.35 7.26 8.13 8.77
Net Debt to EBITDA
-2.77 -3.39 -4.87 -5.93 -5.13 -4.31 0.00 -3.62 -3.37 -4.05 -1.20
Long-Term Debt to EBITDA
7.06 7.33 5.50 7.32 6.60 6.36 0.00 5.91 6.67 7.61 8.12
Debt to NOPAT
23.86 22.48 26.22 26.67 23.02 16.51 0.00 19.02 21.51 23.21 31.25
Net Debt to NOPAT
-8.49 -9.46 -21.11 -20.18 -16.59 -10.42 0.00 -10.85 -10.00 -11.55 -4.29
Long-Term Debt to NOPAT
21.65 20.48 23.85 24.93 21.34 15.38 0.00 17.71 19.76 21.71 28.93
Altman Z-Score
1.18 1.15 1.19 1.13 0.00 0.00 0.00 1.35 1.01 1.28 1.06
Noncontrolling Interest Sharing Ratio
2.02% 2.63% 2.83% 2.55% 2.46% 2.22% 0.00% 6.16% 8.22% 10.24% 10.70%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.83 2.93 2.70 2.79 2.79 2.54 0.00 3.50 2.49 4.37 3.38
Quick Ratio
1.66 1.77 1.66 1.71 1.73 1.83 0.00 2.75 1.66 3.41 2.52
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-176 -4,603 635 14,761 15,425 1,315 4,966 3,693 -1,021 15,252 1,094
Operating Cash Flow to CapEx
132.54% 107.85% 143.26% 177.30% 159.54% 93.13% 74.32% 87.32% 60.58% 35.94% 52.66%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.17 0.17 0.17 0.17 0.18 0.20 0.00 0.24 0.22 0.20 0.15
Accounts Receivable Turnover
6.22 6.38 6.70 6.77 7.83 8.68 0.00 9.28 7.65 7.60 6.35
Inventory Turnover
0.10 0.05 0.04 0.12 12.61 14.18 0.00 14.34 10.68 9.37 0.00
Fixed Asset Turnover
4.03 4.31 4.55 4.28 2.01 1.37 0.00 7.39 8.08 7.01 0.00
Accounts Payable Turnover
0.05 0.02 0.02 0.06 5.29 5.59 0.00 7.14 5.43 4.21 2.16
Days Sales Outstanding (DSO)
58.66 57.23 54.50 53.90 46.64 42.06 0.00 39.34 47.71 48.00 57.50
Days Inventory Outstanding (DIO)
3,654.67 7,230.34 10,013.19 3,101.11 28.95 25.74 0.00 25.45 34.17 38.96 0.00
Days Payable Outstanding (DPO)
6,792.37 15,410.62 19,565.31 6,294.39 68.94 65.29 0.00 51.14 67.27 86.66 169.36
Cash Conversion Cycle (CCC)
-3,079.03 -8,123.05 -9,497.63 -3,139.38 6.65 2.51 0.00 13.65 14.61 0.30 -111.86
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-16,278 -18,172 -24,691 -25,584 -12,424 1,130 0.00 2,630 4,369 1,563 15,226
Invested Capital Turnover
-1.08 -0.94 -0.82 -1.09 -3.77 38.70 0.00 6.87 7.15 2.16 0.88
Increase / (Decrease) in Invested Capital
1,894 6,519 893 -13,160 -13,554 1,130 -2,630 -1,739 2,806 -13,663 190
Enterprise Value (EV)
13,173 3,073 -5,682 -9,174 0.00 0.00 0.00 -2,974 -585 -1,347 -1,868
Market Capitalization
27,216 20,656 25,676 22,463 0.00 0.00 0.00 16,910 15,742 15,062 1,424
Book Value per Share
$21.11 $21.21 $20.89 $20.67 $21.09 $19.64 $0.00 $17.00 $15.64 $13.59 $148.30
Tangible Book Value per Share
$21.11 $21.21 $20.89 $20.67 $21.09 $19.64 $0.00 $17.00 $15.64 $13.59 $148.30
Total Capital
67,617 70,311 67,837 70,757 71,781 66,987 0.00 60,983 60,617 56,808 60,886
Total Debt
41,003 43,077 40,075 42,705 43,076 40,376 0.00 37,154 38,399 36,891 40,146
Total Long-Term Debt
37,207 39,245 36,455 39,928 39,933 37,596 0.00 34,609 35,267 34,513 37,172
Net Debt
-14,593 -18,123 -32,264 -32,313 -31,042 -25,480 0.00 -21,199 -17,849 -18,353 -5,513
Capital Expenditures (CapEx)
6,204 6,378 6,342 5,621 6,097 5,667 7,200 6,002 7,549 5,985 8,758
Debt-free, Cash-free Net Working Capital (DFCFNWC)
9,053 9,839 6,406 6,905 5,782 -2,662 0.00 -763 2,020 4,062 1,508
Debt-free Net Working Capital (DFNWC)
43,070 49,552 47,203 49,847 51,281 38,302 0.00 52,884 30,293 56,148 44,298
Net Working Capital (NWC)
39,274 45,719 43,583 47,070 48,138 35,522 0.00 50,339 27,161 53,770 41,324
Net Nonoperating Expense (NNE)
-521 -321 -1,130 -178 -991 -492 -690 -568 -642 -542 -599
Net Nonoperating Obligations (NNO)
-42,892 -45,405 -52,452 -53,636 -41,129 -25,480 0.00 -21,199 -17,849 -18,353 -5,513
Total Depreciation and Amortization (D&A)
2,409 2,563 2,638 2,856 2,839 2,655 2,634 2,277 2,193 1,917 1,994
Debt-free, Cash-free Net Working Capital to Revenue
48.64% 49.03% 31.02% 33.31% 27.17% -12.18% 0.00% -3.17% 9.52% 22.37% 11.36%
Debt-free Net Working Capital to Revenue
231.42% 246.95% 228.56% 240.51% 240.99% 175.16% 0.00% 219.90% 142.73% 309.24% 333.84%
Net Working Capital to Revenue
211.03% 227.85% 211.03% 227.11% 226.22% 162.44% 0.00% 209.32% 127.98% 296.14% 311.42%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $259.37 $155.54 $237.38 $0.00 $0.00 $0.00 $0.00 $179.47 $0.00
Adjusted Weighted Average Basic Shares Outstanding
1.21B 1.23B 1.26B 1.29B 1.32B 0.00 0.00 0.00 0.00 1.32B 0.00
Adjusted Diluted Earnings per Share
$0.00 $0.00 $259.07 $155.39 $237.17 $0.00 $0.00 $0.00 $0.00 $179.21 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
1.21B 1.23B 1.26B 1.29B 1.32B 0.00 0.00 0.00 0.00 1.32B 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.21B 1.23B 1.26B 1.29B 1.32B 0.00 0.00 0.00 0.00 1.32B 0.00
Normalized Net Operating Profit after Tax (NOPAT)
1,727 1,929 1,715 1,657 1,975 2,473 2,383 2,047 1,896 1,861 1,484
Normalized NOPAT Margin
9.28% 9.61% 8.30% 7.99% 9.28% 11.31% 8.85% 8.51% 8.94% 10.25% 11.18%
Pre Tax Income Margin
16.70% 14.72% 20.31% 12.54% 18.09% 16.25% 15.21% 15.86% 16.52% 15.82% 20.82%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
29.54% 51.40% 31.43% 50.79% 35.32% 53.39% 26.14% 31.02% 33.98% 13.07% 8.76%
Augmented Payout Ratio
44.30% 68.93% 46.92% 78.96% 50.22% 53.61% 38.30% 35.34% 33.98% 13.07% 8.76%

Quarterly Metrics And Ratios for ORIX

No quarterly metrics and ratios for ORIX are available.


Frequently Asked Questions About ORIX's Financials

When does ORIX's fiscal year end?

According to the most recent income statement we have on file, ORIX's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has ORIX's net income changed over the last 6 years?

ORIX's net income appears to be on a downward trend, with a most recent value of $2.24 billion in 2024, falling from $3.03 billion in 2018. The previous period was $2.24 billion in 2023.

What is ORIX's operating income?
ORIX's total operating income in 2024 was $2.39 billion, based on the following breakdown:
  • Total Gross Profit: $18.47 billion
  • Total Operating Expenses: $16.09 billion
How has ORIX revenue changed over the last 6 years?

Over the last 6 years, ORIX's total revenue changed from $26.93 billion in 2018 to $18.61 billion in 2024, a change of -30.9%.

How much debt does ORIX have?

ORIX's total liabilities were at $81.32 billion at the end of 2024, a 7.5% decrease from 2023, and a 1.7% decrease since 2019.

How much cash does ORIX have?

In the past 5 years, ORIX's cash and equivalents has ranged from $6.83 billion in 2024 to $10.43 billion in 2019, and is currently $6.83 billion as of their latest financial filing in 2024.

How has ORIX's book value per share changed over the last 10 years?

Over the last 10 years, ORIX's book value per share changed from 148.30 in 2014 to 21.11 in 2024, a change of -85.8%.



This page (NYSE:IX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners